跳至主要内容
临床试验/CTRI/2024/07/071639
CTRI/2024/07/071639尚未招募不适用

Role of Non invasive Modalities in detecting intracranial haemorrhage and its radiological correlation

Bioscan Research Pvt. Ltd.1 个研究点 分布在 1 个国家目标入组 63 人开始时间: 2024年8月12日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
63
试验地点
1
主要终点
Sensitivity, Specificity, Accuracy and other parameters of CEREBO in determining presence or absence of an intracranial bleed

研究概览

简要总结

This clinical study will evaluate the efficacy of the non-invasive device, CEREBO, in detecting intracranial hemorrhage in patients with traumatic brain injury. The performance of CEREBO will be benchmarked against the gold standard, CT scans. This research aims to demonstrate CEREBO’s capability to identify intracranial hemorrhage at a presymptomatic stage, thereby enabling earlier detection and facilitating prompt intervention. Furthermore, the study will assess the potential reduction in unnecessary CT scans and associated radiation exposure, with a particular focus on vulnerable populations such as infants and pregnant women.

研究设计

研究类型
Observational

入排标准

年龄范围
1.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • Patients with suspected TBI referred for head CT/MRI scan.

排除标准

  • Patients with scalp bruises and hematoma.

结局指标

主要结局

Sensitivity, Specificity, Accuracy and other parameters of CEREBO in determining presence or absence of an intracranial bleed

时间窗: 3 years

次要结局

  • 1. To assess the number of referrals that CEREBO could have prevented from other sites to the study site(2. To assess the usability of CEREBO® among healthcare professionals through survey questionnaires)

研究者

发起方
Bioscan Research Pvt. Ltd.
申办方类型
Other [Research Company]
责任方
Principal Investigator
主要研究者

Dr Hansa Rot

Wockhardt Hospitals, Rajkot

研究点 (1)

Loading locations...

相似试验